Category: CBSA News

By: Fitzsimons Innovation Community This year, Fitzsimons Innovation Community is proudly celebrating 25 years of innovation since the grand opening of Bioscience 1 in 2000. For every one of those 25...

On May 23, the Colorado Prescription Drug Affordability Board (PDAB or Board) became the first PDAB in the country to move toward capping the price of a drug by holding an upper payment limit (UPL) ru...

Grant Funds Advance Groundbreaking Health Innovation in the State DENVER, May 22, 2025 — Boettcher Foundation and Colorado BioScience Association (CBSA) proudly announce the 2025 Class of Boettcher In...

Colorado’s 2025 legislative session, the First Regular Session of the 75th General Assembly, concluded on May 7, the 120th day of session. During the final weeks of this challenging session, the Color...

Colorado Office of Economic Development and International Trade (OEDIT) has announced the newest recipients of state-funded Advanced Industries Accelerator Grants! Colorado BioScience Associ...

The Colorado General Assembly adjourns tonight, Wednesday, May 7, at midnight. Throughout the challenging 120-day session, CBSA’s Policy + Advocacy team worked tirelessly to advocate for policies that...

A Market Outlook for 2025 and Beyond CBRE is the world’s largest commercial real estate services and investment firm, providing services to both occupiers and investors in real estate, with a global p...

Last week, Colorado Bioscience Association (CBSA) Vice President and Counsel for Policy + Advocacy, Amy Goodman, joined state leaders as part of the Biotechnology Innovation Organization (BIO) Council...

Colorado’s legislature is considering two bills related to the federal 340B Drug Pricing Program and both bills are now advancing to the House after passing out of the Senate today.   Colora...

Inspiration, innovation, and thoughts on the future from top women scientists. At Fitzsimons Innovation Community, women in STEM isn’t just a buzz phrase. Many of the innovative companies on our campu...